Related references
Note: Only part of the references are listed.Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy
Kirk E. Cahill et al.
NEURO-ONCOLOGY (2016)
Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles
Tanem Garanti et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Structural Analysis of Metabolites of Asiatic Acid and Its Analogue Madecassic Acid in Zebrafish Using LC/IT-MSn
Binbin Xia et al.
MOLECULES (2015)
Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo
Chandagirikoppal V. Kavitha et al.
MOLECULAR CARCINOGENESIS (2015)
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
Zhaoqing Wang et al.
DEVELOPMENTAL CELL (2014)
Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents
Jian-Fei Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Effects of hypoxia on human cancer cell line chemosensitivity
Sara Strese et al.
BMC CANCER (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Asiatic acid, a triterpene, inhibits cell proliferation through regulating the expression of focal adhesion kinase in multiple myeloma cells
Junli Zhang et al.
ONCOLOGY LETTERS (2013)
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
Liuqi Yang et al.
EXPERIMENTAL CELL RESEARCH (2012)
Asiatic Acid Attenuates Infarct Volume, Mitochondrial Dysfunction, and Matrix Metalloproteinase-9 Induction After Focal Cerebral Ischemia
Ki Yong Lee et al.
STROKE (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Scott M. Welford et al.
MOLECULAR CANCER RESEARCH (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Michael Frezza et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all
Kashmira J. Gohil et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
George C. Bobustuc et al.
NEURO-ONCOLOGY (2010)
Cisplatin Induces Cytotoxicity through the Mitogen-Activated Protein Kinase Pathways and Activating Transcription Factor 3
Carly St Germain et al.
NEOPLASIA (2010)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Glioblastoma cell death induced by asiatic acid
C. W. Cho et al.
CELL BIOLOGY AND TOXICOLOGY (2006)
In vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligands
Georgi Momekov et al.
ARCHIVES OF TOXICOLOGY (2006)
Cytoprotective effects of hypoxia against cisplatin-induced tubular cell apoptosis: Involvement of mitochondrial inhibition and p53 suppression
Jinzhao Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N,N′-bis(salicylidene)-1,2-propanediamine as complexation reagent
SN Lanjwani et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells - Implications for the delayed clearance model of autoimmunity
VA Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells
YL Hsu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
M Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Regulation of transcription and translation by hypoxia
LP Liu et al.
CANCER BIOLOGY & THERAPY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
HIF-1 as a target for drug development
A Giaccia et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxiainducible factor-1 and reactive oxygen species
M Wartenberg et al.
FASEB JOURNAL (2003)
Local chemotherapy with cisplatin-depot for glioblastoma multiforme
SV Sheleg et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates
H Baruah et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Cisplatin-induced renal cell apoptosis: Caspase 3-dependent and -independent pathways
BS Cummings et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Activation of the HIF pathway in cancer
PH Maxwell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)